ABSTRACT
INTRODUCTION
The expected clinical outcome measure of interventional opioid pharmacotherapy for the treatment of acute and chronic pain is analgesia. However, studies indicate that many patients in pain are prescribed inadequate doses of opioid medications to relieve their pain (1) (2) (3) (4) (5) . Multiple barriers to the adequate treatment of pain have been identified (6) (7) (8) (9) 
, but rational opioid dosing founded on pharmacokineticsbased opioid dosing regimens for individual patients has not been adequately addressed. To date, clinical pharmacokinetics-based opioid dosing regimen design and adjustment in acute and chronic
pain management has been the subject of a limited number of publications (10, 11) , although pharmacokinetics-based anesthetic opioid dosing is routine (12) (13) (14) . (15) . This range implies that concentrations above 80 ng/mL are more likely to be associated with toxicity and concentrations below 9.3 ng/mL are more likely to produce little or no analgesic effect. Therefore, in the course of pain management with morphine, it is desirable that a dosage regimen for morphine produce plasma morphine concentrations within its therapeutic range. (16, 17) ; however, opioid pharmacokinetic parameter values are scattered about in the vast pharmacology literature. Therefore, we culled a large number of studies using references (18) (19) (20) (21) 
Opioid maximum concentrations (C max ) and minimum concentrations (C min ) may correspond to their minimum toxic concentrations (MTCs) and minimum effective concentrations (MECs). For example, the therapeutic range of morphine for analgesia is reported to be between 9.3 and 80 ng/mL, MEC range 9.3 to 23 ng/mL

The goal of the design of an opioid dosing regimen is thus to achieve predicted plasma opioid concentrations within or at the boundaries of targeted C max and C min values or a desired target concentrations (C target ).
This contribution introduces a novel application of clinical pharmacokinetics for opioid dosing regimen design and dose adjustment termed computational opioid prescribing (COP). A major aim of COP is the design of individualized opioid dosage regimens for patients in order to
METHODS
Opioid Population Pharmacokinetic Parameter Estimation
Population pharmacokinetic parameter values are often used to estimate drug dosing regimen designs for individual patients in whom patient-specific parameter values are not available
Opioid population pharmacokinetic parameter estimation using the bootstrap (see below) was not performed for F or k a values.
Opioid population pharmacokinetic parameter estimation was performed using the bootstrap resampling technique (24) (25) (26) (27) 
where C target is the targeted plasma opioid concentration. In some cases, administration of a loading dose (D L ) may be necessary:
where C p represents the plasma opioid concentration. For multiple dosing, the accumulation ratio (AR), which represents the ratio of opioid in the body at steady-state relative to the amount of opioid in the body after a single dose, is given by
Hence, the maximum (C ss max ) or peak plasma opioid concentration is given by [9] and the minimum (C ss min ) or trough plasma opioid concentration by
[10]
The average steady-state plasma opioid concentration (Equation 1) can also be obtained using
At any time (T), C p is given by [24] The calculated dose should be adjusted for administration based on available morphine strengths. 
RESULTS
Opioids (N = 1000) t 1 2 (h) k e (h −1 ) V d (L/kg) Cl (L/h/kg)C 1st max = Dose V d = 15, 000µg 4.5L/kg × 86.6kg = 15, 000µg 389.7L = 38.5µg/L C 1st min = C 1st max · e −k eτ = 38.5 × e −0.318×6 = 5.7µg/L AR = 1 1 − e −k e τ = 1 1 − e −0.318×6 = 1.2 [23] C ss max = C 1st max · AR =38.5µg/L × 1.2 = 46.2µg/L C ss min = C 1st min · AR =5.7µg/L × 1.2 = 6.D L = 1.44 · D M · t 1/2 τ = 1.44 × 25.2 × 3.9 hr 6hr = 23.4mg
Extravascular (Oral) Dosing
The computation of dose and dosing interval after extravascular dosing (e.g., oral administration) is slightly more complicated than after intravenous (IV) bolus dosing because the absorption rate (k a ) and
D S (startingdose) = C target · V d F = 40µg/L · 4D M = C target · Cl F = 40µg/L × 1.= τ / t 1/2 = 6/4 = 1.5, then C ss max (peak) = F · D V d · AR = 0.40 × 120, 000µg 4.5L/kg × 137kg · 1.5 = 78µg/L C ss min (trough) = C ss max · e −k e τ · AR = 78µg/L × e −0.318×6 = 17µg/L [ 2 7 ] C ss ave = F · D τ Cl = 0
Constant Intravenous Infusion
To determine intravenous infusion rate we need only determine the infusion rate constant (k 0 ) and do not need to compute τ . To determine a constant rate intravenous infusion of morphine, we estimate k 0 based on a desired morphine C target to achieve, and its Cl, so that k 0 = C target · Cl. We chose a value for C target within morphine's therapeutic window. If rapid achievement of steady-state morphine concentration is desired, an intravenous loading dose may be calculated using Equation 7 or simply 
Opioid Dosing Regimen Evaluation
Dosing regimen evaluation using COP applies to patients who present on a dosage regimen prescribed by another prescriber or an emergency department (ED) physician. The goal is to determine the adequacy of the regimen to achieve evidence-based analgesic plasma concentrations of opioid.
Case Study 3
A 38-year-old average weight man was seen in the ED 24 
Clearly, the patients dosage regimen is inadequate to meet his analgesic needs, since only morphine levels at or above 20 µg/L are considered to be analgesic (15, 37) . Thus, a dosage adjustment, rather than an extensive work-up, was indicated to manage this patients increasing pain.
Case Study 4
A petite 29- [30] Based on this computation, the doctor decides to set C target = 35 µg/L, which is the average value between C ss max and C t (30) , to calculate a maintenance dose: 
